Another trial via the Swiss Group (SAKK) enrolled cytologically or histologically proven IIIA (N2) sufferers which were being then randomized into preoperative chemotherapy followed by operation compared to sequential neo-adjuvant chemotherapy after which you can radiotherapy followed by medical procedures; the key plus the secondary endpoints from